PURPOSE: Expression of the protein subunits that make up the γ-aminobutyric acid (GABA)(A) receptor pentamer is known to change during postnatal brain development in animal models. In the present study, analysis of cortical GABA(A) subunit expression was performed in control human tissue obtained from infancy through adolescence, and was compared to that from similarly aged children with intractable focal epilepsy. METHODS: Twenty frozen pediatric control and 25 epileptic neocortical specimens were collected. The membrane fractions were isolated and subjected to quantitative western blot analysis. Subunit expression was correlated with clinical factors including age, pathology, and medication exposure. RESULTS: In control cortical samples, α₁ and γ₂ GABA(A) receptor subunits exhibited low expression in infancy, which increased over the first several years of life and then stabilized through adolescence. In contrast, α₄ subunit expression was higher in infants than in older children. The level of the chloride transporter KCC2 increased markedly with age, whereas that of NKCC1 decreased. These patterns were absent in the children with epilepsy, both in those with focal cortical dysplasia and in those with cortical gliosis. Although there was marked variability in GABA(A) receptor subunit expression among the children with epilepsy, identifiable patterns of subunit expression were found in each individual child. DISCUSSION: Maturation of cortical GABA(A) receptor subunit expression continues over the first several years of postnatal human development. Intractable focal epilepsy in children is associated with disruption of this normal developmental pattern. These findings have significant implications for the treatment of children with medications that modulate GABA(A) receptor function. Wiley Periodicals, Inc.
PURPOSE: Expression of the protein subunits that make up the γ-aminobutyric acid (GABA)(A) receptor pentamer is known to change during postnatal brain development in animal models. In the present study, analysis of cortical GABA(A) subunit expression was performed in control human tissue obtained from infancy through adolescence, and was compared to that from similarly aged children with intractable focal epilepsy. METHODS: Twenty frozen pediatric control and 25 epileptic neocortical specimens were collected. The membrane fractions were isolated and subjected to quantitative western blot analysis. Subunit expression was correlated with clinical factors including age, pathology, and medication exposure. RESULTS: In control cortical samples, α₁ and γ₂ GABA(A) receptor subunits exhibited low expression in infancy, which increased over the first several years of life and then stabilized through adolescence. In contrast, α₄ subunit expression was higher in infants than in older children. The level of the chloride transporter KCC2 increased markedly with age, whereas that of NKCC1 decreased. These patterns were absent in the children with epilepsy, both in those with focal cortical dysplasia and in those with cortical gliosis. Although there was marked variability in GABA(A) receptor subunit expression among the children with epilepsy, identifiable patterns of subunit expression were found in each individual child. DISCUSSION: Maturation of cortical GABA(A) receptor subunit expression continues over the first several years of postnatal human development. Intractable focal epilepsy in children is associated with disruption of this normal developmental pattern. These findings have significant implications for the treatment of children with medications that modulate GABA(A) receptor function. Wiley Periodicals, Inc.
Authors: Faye S Silverstein; Frances E Jensen; Terrie Inder; Lena Hellstrom-Westas; Deborah Hirtz; Donna M Ferriero Journal: J Pediatr Date: 2008-07 Impact factor: 4.406
Authors: Yogendrasinh H Raol; Guojun Zhang; Ingrid V Lund; Brenda E Porter; Margaret A Maronski; Amy R Brooks-Kayal Journal: Epilepsia Date: 2006-10 Impact factor: 5.864
Authors: Carlos Cepeda; Véronique M André; Nanping Wu; Irene Yamazaki; Besim Uzgil; Harry V Vinters; Michael S Levine; Gary W Mathern Journal: Epilepsia Date: 2007 Impact factor: 5.864
Authors: Arjune Sen; Lillian Martinian; Margareta Nikolic; Matthew C Walker; Maria Thom; Sanjay M Sisodiya Journal: Epilepsy Res Date: 2007-03-06 Impact factor: 3.045
Authors: John Peyton Bohnsack; Benjamin A Hughes; Todd K O'Buckley; Kamyra Edokpolor; Joyce Besheer; A Leslie Morrow Journal: Neuropsychopharmacology Date: 2018-02-27 Impact factor: 7.853
Authors: Henner Koch; Sebastien Zanella; Gina E Elsen; Lincoln Smith; Atsushi Doi; Alfredo J Garcia; Aguan D Wei; Randy Xun; Sarah Kirsch; Christopher M Gomez; Robert F Hevner; Jan-Marino Ramirez Journal: J Neurosci Date: 2013-02-20 Impact factor: 6.167
Authors: Christine S Cheah; Ruth E Westenbroek; William H Roden; Franck Kalume; John C Oakley; Laura A Jansen; William A Catterall Journal: Channels (Austin) Date: 2013-08-21 Impact factor: 2.581